Given the fact that Treg cells control autoimmunity and inhibit anti-cancer immunity, c-FLIP could be used as a therapeutic target to modulate Treg cell abundance and immune responses in cancer or autoimmune disease [63]. This evidence concerns the gene CFLAR and autoimmune disease.